BROMDAY

◄ 1/9 ►

BROMDAY Investigators


• BROMDAY [package insert]. Irvine, CA: ISTA Pharmaceuticals, Inc; 2010.
• Data on file. ISTA Pharmaceuticals, Inc.

INDICATIONS AND USAGE
BROMDAY is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.

DOSAGE AND ADMINISTRATION
Instill one drop into the affected eye(s) once daily beginning 1 day prior to surgery, continued on the day of surgery and through the first 14 days post-surgery.

WARNINGS AND PRECAUTIONS
• Sulfite allergic reactions
• Slow or delayed healing
• Potential for cross-sensitivity
• Increase bleeding of ocular tissues
• Corneal effects including keratitis
• Contact lens wear

ADVERSE REACTIONS
The most commonly reported adverse reactions in 2-7% of patients were abnormal sensation in eye, conjunctival hyperemia and eye irritation (including burning/stinging).

1,819 video views and 13,752 series views since

  • Bookmark
  • QuickLink
Request More
Information
on BROMDAY Register for Web
Teleconference Download
Prescribing
Information

BROMDAY is indicated only for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. ISTA Pharmaceuticals is not responsible for content and links in this website that may deal with on or off-label content.

© 2010 ISTA Pharmaceuticals, Inc. All rights reserved. BQD625-10/10